{"doi":"10.1016/j.bbmt.2020.08.015","title":"Peritransplantation Use of Ruxolitinib in Myelofibrosis","abstract":null,"journal":"Biology of Blood and Marrow Transplantation","year":2020,"id":637772,"datarank":0.29188652235829704,"base_score":1.9459101490553132,"endowment":1.9459101490553132,"self_citation_contribution":0.29188652235829704,"citation_network_contribution":0.0,"self_endowment_contribution":0.29188652235829704,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1656154,"name":"Giulia Eva Maria Petrone","orcid":null,"position":1,"is_corresponding":false},{"id":266853,"name":"John Mascarenhas","orcid":"0000-0002-8400-0483","position":2,"is_corresponding":false},{"id":284252,"name":"Alla Keyzner","orcid":"0000-0001-6272-8257","position":3,"is_corresponding":false},{"id":1217465,"name":"Uroosa Ibrahim","orcid":"0000-0003-0088-5438","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Peritransplantation Use of Ruxolitinib in Myelofibrosis","abstract":"Ruxolitinib is an oral JAK1/2 inhibitor that is approved for use in patients with intermediate and high-risk myelofibrosis (MF) based on its proven spleen and symptom burden reduction. Its impact on hematopoietic stem cell transplantation (HSCT) outcomes is largely unknown, however. A significant number of patients proceeding to HSCT have been treated with ruxolitinib, and the specifics of its peritransplantation use vary widely in the published literature. Here we review the currently published data and experience to guide management of patients with MF on ruxolitinib proceeding to HSCT.","is_dataset_classified":null,"base_score":1.9459101490553132,"endowment":1.9459101490553132,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"32818555","pmcid":null,"openalex_id":"https://openalex.org/W3076180738","authors":[],"funders":[],"total_grants":0,"fwci":0.1123,"citation_percentile":0.44358903,"influential_citations":0,"citation_trend":[{"year":2021,"count":1},{"year":2024,"count":1},{"year":2025,"count":4}],"oa_status":"hybrid","license":"cc-by-nc-nd","oa_locations":[{"url":"https://doi.org/10.1016/j.bbmt.2020.08.015","host_type":"journal"},{"url":"https://doi.org/10.1016/j.bbmt.2020.08.015","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1083879120305073?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1083879120305073?httpAccept=text/plain","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/32818555","host_type":"repository"}],"fields_of_study":["Myeloproliferative Neoplasms: Diagnosis and Treatment","Chronic Myeloid Leukemia Treatments","Eosinophilic Disorders and Syndromes","Hematopoietic Stem Cell Transplantation","Humans","Nitriles","Primary Myelofibrosis","Protein Kinase Inhibitors","Pyrazoles","Pyrimidines"],"mesh_terms":["Humans","Nitriles","Pyrazoles","Pyrimidines","Hematopoietic Stem Cell Transplantation","Protein Kinase Inhibitors","Primary Myelofibrosis"],"keywords":["Ruxolitinib","Myelofibrosis","Medicine","Extramedullary hematopoiesis","Hematopoietic stem cell transplantation","Internal medicine","Intensive care medicine","Oncology","Transplantation","Haematopoiesis","Stem cell","Bone marrow","HSCT","Allogeneic Transplant"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T19:29:06.327305Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}